Mol Cell Biol. 1994 April; 14(4): 2411-2418
Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes.
R Philip,
E Brunette,
L Kilinski,
D Murugesh,
M A McNally,
K Ucar,
J Rosenblatt,
T B Okarma and
J S Lebkowski
Applied Immune Sciences, Inc., Santa Clara, California 95054.
ABSTRACT
We have used cationic liposomes to facilitate adeno-associated virus (AAV) plasmid transfections of primary and cultured cell types. AAV plasmid DNA complexed with liposomes showed levels of expression several fold higher than those of complexes with standard plasmids. In addition, long-term expression (> 30 days) of the gene, unlike the transient expression demonstrated by typical liposome-mediated transfection with standard plasmids, was observed. Southern analysis of chromosomal DNA further substantiated the hypothesis that the long-term expression was due to the presence of the transgene in the AAV plasmid-transfected group and not in the standard plasmid-transfected group. AAV plasmid-liposome complexes induced levels of transgene expression comparable to those obtained by recombinant AAV transduction. Primary breast, ovarian, and lung tumor cells were transfectable with the AAV plasmid DNA-liposome complexes. Transfected primary and cultured tumor cells were able to express transgene product even after lethal irradiation. High-level gene expression was also observed in freshly isolated CD3+, CD4+, and CD8+ T cells from normal human peripheral blood. Transfection efficiency ranged from 10 to 50% as assessed by intracellular interleukin-2 levels in interleukin-2-transfected cells. The ability to express transgenes in primary tumor and lymphoid cells may be applied toward tumor vaccine studies and protocols which may eventually permit highly specific modulation of the cellular immune response in cancer and AIDS.
Mol Cell Biol. 1994 April; 14(4): 2411-2418
This article has been cited by other articles:
-
Nakai, H., Yant, S. R., Storm, T. A., Fuess, S., Meuse, L., Kay, M. A.
(2001). Extrachromosomal Recombinant Adeno-Associated Virus Vector Genomes Are Primarily Responsible for Stable Liver Transduction In Vivo. J. Virol.
75: 6969-6976
[Abstract]
[Full Text]
-
Malik, A. K., Monahan, P. E., Allen, D. L., Chen, B.-G., Samulski, R. J., Kurachi, K.
(2000). Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer. J. Virol.
74: 3555-3565
[Abstract]
[Full Text]
-
Ding, Y., Qin, L., Kotenko, S. V., Pestka, S., Bromberg, J. S.
(2000). A Single Amino Acid Determines the Immunostimulatory Activity of Interleukin 10. J. Exp. Med.
191: 213-224
[Abstract]
[Full Text]
-
Tang, X., Mohuczy, D., Zhang, Y. C., Kimura, B., Galli, S. M., Phillips, M. I.
(1999). Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension. Am. J. Physiol. Heart Circ. Physiol.
277: H2392-H2399
[Abstract]
[Full Text]
-
D’Ovidio, F., Yano, M., Ritter, J. H., Mohanakumar, T., Patterson, G. A.
(1999). Endobronchial transfection of naked TGF-{beta}1 cDNA attenuates acute lung rejection. Ann. Thorac. Surg.
68: 1008-1013
[Abstract]
[Full Text]
-
Duan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., Fisher, K. J., Engelhardt, J. F.
(1998). Circular Intermediates of Recombinant Adeno-Associated Virus Have Defined Structural Characteristics Responsible for Long-Term Episomal Persistence in Muscle Tissue. J. Virol.
72: 8568-8577
[Abstract]
[Full Text]
-
Punch, J. D., Tono, T., Qin, L., Bishop, D. K., Bromberg, J. S.
(1998). Tolerance Induction by Anti-CD2 Plus Anti-CD3 Monoclonal Antibodies: Evidence for an IL-4 Requirement. J. Immunol.
161: 1156-1162
[Abstract]
[Full Text]
-
Gardner, J. P., Zhu, H., Colosi, P. C., Kurtzman, G. J., Scadden, D. T.
(1997). Robust, But Transient Expression of Adeno-Associated Virus-Transduced Genes During Human T Lymphopoiesis. Blood
90: 4854-4864
[Abstract]
[Full Text]
-
Seguret-Mace, S., Latta-Mahieu, M., Castro, G., Luc, G., Fruchart, J.-C., Rubin, E., Denefle, P., Duverger, N.
(1996). Potential Gene Therapy for Lecithin-Cholesterol Acyltransferase (LCAT)–Deficient and Hypoalphalipoproteinemic Patients With Adenovirus-Mediated Transfer of Human LCAT Gene. Circulation
94: 2177-2184
[Abstract]
[Full Text]
Copyright © 1994 by the American Society for Microbiology. All rights reserved.